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Abstract 
Objectives: Injection of a topical anaesthetic has been proved to be helpful with reducing pain after laparoscopic 
herniorrhaphy. We aimed to assess the effect of bupivacaine lavage on postoperative pain and compare it with 
diclofenac suppository. In this randomized clinical trial, 60 patients—scheduled for laparoscopic herniorrhaphy—were 
enrolled and randomized into three groups of 20 each, including diclofenac suppository, bupivacaine lavage, and 
normal saline as a placebo.The patients were investigated for postoperative pain scores, vomiting, nausea, morphine 
request, and duration of hospitalization.
Results: In the bupivacaine group, pain levels in recovery room, 4, 8 and 12 h after surgery, were significantly lower 
than diclofenac group; at time points of 16, 20 and 24 h after surgery, difference between two groups was not signifi-
cant. Regarding vomiting and nausea, at time points of 1 and 3 h after surgery, results show no significant difference 
between the groups. Incident of infection, 1 h and 1 week after the surgery, was not significantly different among 
the groups. Duration of hospitalization in the bupivacaine group was much lower than the diclofenac group. Based 
on our results, use of the bupivacaine lavage can reduce postoperative pain in patients undergoing laparoscopic 
herniorrhaphy.
Trial Registration Randomized clinical trial IRCT20180522039782N2; date of registration:14/10/2018
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Introduction
In recent years, repair of inguinal hernia with less inva-
sive modern surgical techniques has minimized the pos-
sibility of relapse, and pared its acute postoperative pain, 
and improved patients’ satisfaction as well. However, 
despite the consistent advances, controlling postopera-
tive chronic pain in this kind of surgery is still a challenge.
Additional beneficial effects of less invasive surgical 
methods, such as laparoscopy, include a reduction in 
hospitalization costs, enhancing patients’ quality of life, 
raising the standard of health care and faster re-engage-
ment of the patients in daily activities [1]. However, the 
research to date has failed to resolve the issue of control-
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algorithm has been introduced for it. This indicates the 
need for further attention to developing a multifaceted 
management approach for ameliorating postoperative 
pain of inguinal herniorrhaphy [2].
Non-steroidal anti-inflammatory drugs (NSAIDs) are 
a popular category of drugs for controlling postoperative 
pain which in short-term have the least side effects. In 
this category, analgesic diclofenac, reduces patient’s need 
to opioids after surgery and alleviates peritoneal pain and 
inflammation as well [3].
Another method for controlling postoperative pain 
is interapritoneal lavage with bupivacaine from surgi-
cal site which is sometimes exploited by surgeons [4, 
5]. Bupivacaine is a long-acting local anesthetic drug 
which is very efficient in relieving postoperative pains. 
Although numerous studies have investigated several 
possible methods and drugs for controlling and relieving 
postoperative pain of laparoscopic transabdominal pre-
peritoneal (TAPP) surgery of inguinal hernia, to the best 
of our knowledge, there is no record of a study in which 
the effects of bupivacaine and analgesic diclofenac have 
been compared [6–11]. In this randomized clinical trial, 
these two drugs are compared regarding their efficiency 
for pain after laparoscopic herniorrhaphy.
Additionally, a comparison has been drawn regarding 
duration of hospitalization, surgical wound infection, 




For this study, a total of 60 patients were recruited from 
the General Surgery Department of Rasoul Akram Hos-
pital during the year of 2018. According to the inclu-
sion criteria of this study, male or female patients of 
American Society of Anesthesiologists Class 1 or 2 who 
were candidate for laparoscopic herniorrhaphy were 
included in the study. Also, due to anticipated medica-
tion side effects, pregnancy was considered as the exclu-
sion criterion. Moreover, patients whose procedure 
was converted to open herniorrhaphy were excluded 
from the study. Prior to commencing the study, the 
patients were explained about the procedure and a writ-
ten informed consent was obtained from them. All the 
included patient had underwent general anesthesia and 
had same anesthetic management without any admin-
istration of additional narcotic drugs, intraoperatively. 
The procedures of this study were approved by Ethical 
Committee of Iran Registry of University of Medical Sci-
ence (IR.IUMS.FMD.REC1396.9311245006) and regis-
tered with Iran Randomized Clinical Trial Center (no: 
IRCT20180522039782N2).The study adheres to CON-
SORT guidelines for reporting this trial.
For the purpose of this study, according to the study of 
Suvikapakornkul et  al. [12], the required sample size of 
each group was calculated as 20.
Study power = 90%
Patients in these groups were treated by bupivacaine, 
analgesic diclofenac and normal saline, separately. In 
the bupivacaine lavage group, the lavage was performed 
using a suction irrigation setting just before desuffla-
tion of the abdomen and closing the surgical site. In 
this group, 0.25% bupivacaine in 100 ml of physiological 
serum was used.
The patients were placed in the supine position and 
bupivacaine lavage was performed through the umbili-
cal into the abdominal cavity. A diclofenac suppository 
50 mg was prescribed for the diclofenac group every 8 h; 
the first dose was administrated immediately after the 
surgery. One g IV stat of paracetamol was infused for all 
the patients after the surgery. A questionnaire includ-
ing variables such as postoperative visual analogue scale 
(VAS), vomiting, nausea, age, gender, request for rescue 
morphine, duration of hospitalization was completed by 
a staff member for each patient. These variables were reg-
istered at time points of 0 (in the recovery room), 4, 8, 12, 
16, 20, and 24 h after the surgery. Then, the collected data 
were analyzed and interpreted using SPSS version 22. 
To analyze qualitative variables, frequency and percent-
age were reported and compared using chi-square test. 
Regarding quantitative variables, the mean and standard 
deviation were presented.
Comparisons between the quantitative variables were 
done using the t-test (for normal distribution), and the 
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used. To compare the groups, the Analysis of Variance 
(ANOVA) or the Kruskal Wallis was used. A P value less 
than of 0.05 was considered significant.
Results
In this randomized clinical trial, 60 patients were divided 
into three groups of 20 each. The first group, consisted of 
16 men (80%) and 4 women (20%) with mean age of 47.05, 
were administered with bupivacaine lavage, and the sec-
ond group, consisted of 17 men (85%) and 3 women (5%) 
with mean age of 51.75 received analgesic diclofenac. The 
control group consisted of 18 men (90%) and 2 women 
(10%) with mean age of 48.1 and they were treated with 
normal saline (Table1). The comparison of the analyzed 
data— collected at the time points of 0  h (at recovery 
room), 4, 8, 12, 16, 20, 24 h after the surgery— revealed a 
significant difference between the three groups regarding 
pain levels experienced (P < 0.05). Pair wise comparisons 
also indicated that in the bupivacaine group, postopera-
tive pain levels were significantly less than the analgesic 
diclofenac group and the control group (P < 0.05). Moreo-
ver, the pain levels of the analgesic diclofenac group were 
less than those of the control group. However, none of 
the differences at the time points of 16, 20 and 24 h after 
the surgery, between the three groups, were statistically 
significant; accordingly, the pain levels of the bupivacaine 
group and analgesic diclofenac group were not signifi-
cantly different at these time points. The mean postop-
erative pain at the time points of 0, 4, 8, 12, 16  h after 
the surgery was significantly different between the three 
groups. Pair comparison of the groups showed that the 
mean postoperative pain was significantly lower in the 
bupivacaine group compared with the diclofenac and 
control groups (P value ˂ 0.05) (Fig. 1).
To draw a comparison between the three groups in 
terms of experiencing nausea and vomiting, the Chi-
Square Test method was used. This comparison disclosed 
that at the time point of 1 h after the surgery, the three 
groups were not significantly different, regarding the 
incident of nausea and vomiting (P > 0.05). Similarly, at 
the time point of 3 h after the surgery, no difference was 
found between the groups (Table 2).
Regarding the incident of infection 1  week after the 
surgery, the Chi-Square Test showed that the three 
groups did not differ significantly (P > 0.05) (Additional 
file 1. Table S1).
The Chi-Square Test was applied to studying the 
request for rescue pain killer in the three groups. While 
the demand for rescue painkiller was higher in the con-
trol group (P < 0.05), the results confirmed that, undoubt-
edly, there was a positive association between the use of 
bupivacaine lavage and request for painkiller (P < 0.05) 
(Additional file 1. Table S2). The Kruskal Wallis test was 
used to determine and evaluate the hospitalization peri-
ods of the patients; the results, as shown in (Additional 
file  1. Table  S3), interestingly demonstrate a significant 
difference between the groups (P < 0.05). Moreover, pair 
wise comparisons assert that the patients in the bupi-
vacaine lavage group required a significantly less hos-
pitalization period (P < 0.05when compared with the 
analgesic diclofenac group. Certainly, the hospitalization 
Table 1 The comparison of age and gender between the 3 groups
There were no statistically significant differences between the age and gender of the patients (p value > 0.05) in the 3 groups
Characteristics Groups P value
Bupivacaine lavage Diclofenac suppository Control
Age(year)
SD ± Average 47.05 ± 13.1 51.75 ± 11.23 48.1 ± 11.25 0.429
Sex
Male 16 (80%) 17 (85%) 18 (90%) 0.676
Female 4 (20%) 3 (15%) 2 (10%)
Fig. 1 The trend of VAS score changes over the assessed times
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time in the bupivacainelavage group was less than that in 
the control group (P < 0.05).
Discussion
The repair of TAPP and total extraperitoneal (TEP) repair 
are two of the most frequent laparoscopic repair meth-
ods for inguinal hernia. Laparoscopic repair of inguinal 
hernia should be performed by a surgeon familiar with 
traditional anterior repair and laparoscopic technique as 
well as an extensive insight into anatomy of the inguinal 
general area and posterior view of the anterior abdominal 
wall [1]. With improving the laparoscopic techniques and 
surgeon’s skills, the probability of relapse can be reduced 
to the extent reported for the traditional techniques of 
hernia repair. Postoperative pain is recognized as an 
undesirable outcome and widely discussed in the lit-
erature. However, none of them can be considered as an 
efficient method to reducing postoperative pain. Unfor-
tunately, there is still a little understanding about the 
contributing factors, leading to various pain syndromes 
before, during and after the surgery. Actually, depending 
on the root cause, these syndromes could be intrinsically 
somatic or visceral and their treatment might be compli-
cated [2].
The present study aimed to determine the effect of 
the bupivacaine lavage and diclofenac suppository on 
postoperative pain in laparascopic herniorrhaphy and to 
compare them which each other.
In our study, pain scores and hospitalization periods 
were considerable improved in the patients treated with 
bupivacaine lavage,, compared to the patients treated 
with diclofenac suppository.
Gupta et  al. (2016) compared ropivacaine 0.25% and 
0.5% with bupivacaine 0.25% in a group of 90 patients 
underwent inguinal herniorrhaphy and they observed 
that postoperative VAS pain scores for the bupivacaine 
0.25% group improved. Their findings, consistent with 
our findings, confirmed that bupivacaine causes no 
nausea and vomiting as side effects [13]. Savestani et al. 
(2013) examined the pain relieving effect of intraperi-
toneal instillation of hydrocortisone and compared it 
with normal saline. The numerical rating scale (NRS) 
pain scores in hydrocortisone group were significantly 
lower than normal saline group. Moreover, the hydro-
cortisone group showed less demand doses of pain 
killer besides no sign of nausea and vomiting [14].
Surveys such Saeed Safari et  al.’ study (2020) have 
shown that individuals, who received intraperitoneal 
lavage of bupivacaine 0.2% in laparascopic bariatric 
surgeries, experienced lower pain scores on coughing 
and resting compared with those in placebo group. Fur-
thermore, the studies have shown that intraperitoneal 
lavage of bupivacaine is a simple and an effective tech-
nique for controlling the postoperative pain of laparas-
copic bariatric surgeries [15].
Moreover, a considerable amount of previous stud-
ies have reported the positive effects of bupivacaine on 
alleviating pain after laparascopic cholecystectomy. For 
instance, Abdul Manan et al. in 2020, in a randomized 
clinical trial, investigated 55 patients underwent lapa-
roscopic cholecystectomy for the effect of bupivacaine 
against a 55-patient placebo group. Based on finding of 
this study, we conclude that analgesia duration after the 
surgery in bupivacaine group was significantly higher 
than placebo group [16]. Suma S. et al. in 2019 treated 
two groups of 34- patient separately with bupivacaine 
lavage and normal saline lavage as placebo at the gall 
bladder fossa.
Moreover, our finding led us to conclude that bupiv-
acaine lavage was more effective on controlling postop-
erative pain of laparascopic cholecystectomy compared 
with the placebo. The mean of pain score in the bupi-
vacaine group was significantly less than the placebo 
group [17]. The consistent results of these studies and 
their findings support the idea of potency of lavage 
method in relieving postoperative pain of laparascopic 
surgeries; nevertheless, there are a few limitations and 
the results are not always as desired. Further investiga-
tions are required to explore safer and more effectual 
drugs for alleviating postoperative pains.
Table 2 The comparison of postoperative nausea and vomiting between the 3 groups
There were no statistically significant differences in nausea and vomiting 1 and 3 hr after surgery between the 3 groups
Time Groups Nausea and vomiting P value
Bupivacaine lavage Diclofenac suppository Control
1 h postopration 3 (15%) 3 (15%) 4 (20%) Yes 0.887
17 (85%) 17 (85%) 16 (80%) No
3 h postopration 1 (5%) 1 (15%) 3 (15%) Yes 0.418
19 (95%) 19 (95%) 17 (85%) No
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Limitations
This study extends our knowledge on postoperative pain 
relieving methods; however, the findings were limited 
because of the use of a relatively small size group; there-
fore, they should be interpreted with caution. In this 
regard, it is recommended to perform further researches 
with larger group sizes.
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